M.D. Anderson Cancer Center: all 3,044 studies

Page 1 of 31. Open to participants first (578), then studies with results posted, then the rest; newest registration first within each.

• Estimating The Rate Of Complete Ablation (A0) With The Use Of Biomechanical Deformable Image RegistrationNot yet recruitingNCT07877220Not applicable
• PROACT AYA: Preventing Overweight/Obesity-Associated Cardiotoxicity With Tirzepatide In Adolescent And Young Adult Cancer Survivors - A Phase 2 Single-Arm, Single-Center Feasibility StudyRecruitingNCT07874828Phase 2
• Food Is Medicine In Survivorship (Foodiis-AYA): Examining The Feasibility And Acceptability Of A Remotely-Delivered Meal Kit And Culinary Medicine Program For Survivors Of Adolescent/Young Adult (AYA) CancerNot yet recruitingNCT07871773Not applicable
• Long-Term Quality Of Life And Symptom Assessment Among Recurrence-Free Patients Who Underwent Cytoreductive Surgery and Hyperthermic Intraperitoneal ChemotherapyNot yet recruitingNCT07871760
• Prospective Study To Assess The Outcomes Of Nitrous Oxide Cryoablation For Treatment Of Duodenal Adenomas In Patients With Hereditary Conditions Such As FAP, HNPCCNot yet recruitingNCT07859514Not applicable
• 2 Gy Total Body Irradiation As Part Of Conditioning Treatment For Patients With Acute Lymphoblastic Leukemia Undergoing CAR T Cell TherapyNot yet recruitingNCT07856758Not applicable
• A Ph2, Colchicine For Inflammatory Carotid Injury And Disease Evolution After RadiotherapyNot yet recruitingNCT07856719Phase 2
• Prediction Of Lymphedema In Patients With Inflammatory BreastCancer Using Preoperative Bioimpedance MeasurementsRecruitingNCT07855627
• Understanding the Role of MyCareGorithm as a Visual Digital Platforms in Cancer Treatment Education and Patient Comprehension of Oncology Treatment PlansNot yet recruitingNCT07852949Not applicable
• Supporting Families In Coping With Parental Cancer: A Multi-Site Randomized Controlled TrialNot yet recruitingNCT07852858Not applicable
• Phase 1/2 Study Of PARP Inhibition With Olaparib To Enhance The Efficacy Of High-Dose Chemotherapy In Refractory And Relapsed Germ Cell TumorsNot yet recruitingNCT07850973Phase 1/2
• A Phase 1/2 Trial Of Larotrectinib And Pembrolizumab In Patients With Solid Tumors Previously Treated With Immune Checkpoint Inhibitor MonotherapyNot yet recruitingNCT07843550Phase 1/2
• MINTER Trial: Metal Intervention aNd ThErapy With Radiotherapy In Thoracic Cancer Using Copper Donor Therapy: A Phase 2, Open-Label StudyNot yet recruitingNCT07843537Phase 2
• Proactively Intervening On Early Cranial Nerve Injury As A Delayed Sequela Of Oropharyngeal Cancer: A Randomized Feasibility Clinical Trial For Pro-Habilitation (proNERVE RCT)Not yet recruitingNCT07832266Phase 1
• Impact of Routine Electronic Patient-Reported Outcome (ePRO)Symptom Monitoring During Neoadjuvant Therapy in Patients withPancreatic Adenocarcinoma on Patient Experience and ClinicalOutcomes: A Prospective Pre-Post Implementation StudyNot yet recruitingNCT07829471Not applicable
• PRECISE LBCL: Precision Treatment Readiness Through Comprehensive Genomic Sequencing in 1st Line LBCLNot yet recruitingNCT07829445
• Spatial Computing With the Apple Vision Pro in Image-guided ProceduresRecruitingNCT07819513
• Optimizing Tumor-Infiltrating Lymphocyte (TIL) Harvest Site and Patient Selection With CD8-PET Imaging in Patients WithNot yet recruitingNCT07819474Not applicable
• Prospective Observational Study Of Geniculate Artery Embolization For Symptomatic Knee Osteoarthritis In A Cancer PopulationRecruitingNCT07807943
• Prospective Collection And Molecular Analysis Of Biospecimens And Clinical Data From Patients With Urothelial Carcinoma And Related Malignancies Of The Urinary TractRecruitingNCT07789119
• Prospective Randomized Study of TPS + CBT VS TPS Alone: Readmission, Opioid Use, and Chronic PainNot yet recruitingNCT07783672Not applicable
• Zotatifin And EIF4A Platinum Helix Inhibition In Resistant AdvancedTNBCNot yet recruitingNCT07783659Phase 1
• Randomized Phase 2 Study Of Epcoritamab Vs Watch And Wait InPatients With Previously Untreated Low Tumor Burden FollicularLymphomaNot yet recruitingNCT07783594Phase 2
• RAPID: Phase 2 Platform Trial Of Promising Drugs For AYA Patients With R/R Ewing Sarcoma & DSRCTNot yet recruitingNCT07781891Phase 2
• Study of Monzosertib In Patients With R/R AML Or High-Risk Myelodysplastic SyndromeNot yet recruitingNCT07780565Phase 1
• Efficacy Of An Inpatient Yoga Therapy Program For Cancer PatientsNot yet recruitingNCT07776587Not applicable
• Chatbot Implementation In The Clinical Informed Consent ProcessNot yet recruitingNCT07756515Not applicable
• A Phase II Study of Ivonescimab Combined With Intraperitoneal Paclitaxel in Patients With High-Grade Metastatic Appendiceal Adenocarcinoma (AA)Not yet recruitingNCT07753824Phase 2
• Bone Marrow Imaging and Clinical Outcomes Across Hematologic, Oncologic, and Other Relevant ConditionsRecruitingNCT07743476
• STOMP OUT: A Phase 2 Study To Evaluate The Effects Of Ivonescimab In Patients With Unresectable/Metastatic Adrenocortical Carcinoma (ACC) Or Unresectable Pheochromocytoma/Paraganglioma (PPGL)Not yet recruitingNCT07743138Phase 2
• Development Of An Endometrial Cancer Educational ToolNot yet recruitingNCT07739745Not applicable
• RISE: Reducing Cancer and HIV Stigma Through EmpowermentNot yet recruitingNCT07728370Not applicable
• Dissemination Of Lung Cancer Screening Education Through Tobacco QuitlinesNot yet recruitingNCT07720141Not applicable
• A Phase 1 Trial Of Safety And Initial Efficacy Of Vagal Nerve Blockade For Cancer-Induced Cachexia In Patients With Metastatic Pancreatic AdenocarcinomaNot yet recruitingNCT07700212Phase 1
• Study Of KITE-753 in R/R B-Cell ALLNot yet recruitingNCT07674823Phase 1
• A Phase 2 Trial Of The Combination Of Zanubrutinib, Sonrotoclax, And Obinutuzumab For Patients With Treatment-Naïve Chronic Lymphocytic LeukemiaNot yet recruitingNCT07674810Phase 2
• Oncologic Timely Palliative Care And Remote Monitoring With Electronic Assessments And Telehealth (ON-TARGET)Not yet recruitingNCT07674797Not applicable
• Prospective Observational Study of Outcomes After Gemcitabine, Docetaxel, Melphalan, and Carboplatin With Autologous Stem Cell Transplantation in Pediatric Relapsed/Refractory Germ Cell TumorsRecruitingNCT07662018
• OBSERVE: A Pilot Study Of Omission Of Brain Metastasis Stereotactic Radiosurgery Following Resection With CNS-Active Systemic TherapyRecruitingNCT07655583Phase 1
• Pilot Study of Ivonescimab in Advanced/Metastatic Cutaneous AngiosarcomaRecruitingNCT07655570Phase 2
• Phase 2 Trial of G207 + 5 Gy Radiation for Children With High-Grade GliomasRecruitingNCT07649070Phase 2
• A Phase 1b/2 Study of Ropeginterferon Alfa-2b Added to Azacitidine in MDS/AML With TP53 MutationsRecruitingNCT07646821Phase 1/2
• A Phase 1b, Open-Label Study Of REC-617, A Selective CDK7 Inhibitor, In Patients With Metastatic Or Unresectable RB1-Negative Leiomyosarcoma After Prior Systemic TherapyRecruitingNCT07633756Phase 1
• Wearable Device Tracked Recovery From Autologous Breast Reconstructive SurgeryNot yet recruitingNCT07631026Not applicable
• Phase 1 Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cell In Patients With Oral Premalignant LesionsNot yet recruitingNCT07631013Phase 1
• Blood and imagE-guided Optimization of Neoadjuvant Therapy in People With Early Stage Triple-negative Breast cancER - the BETTER TrialNot yet recruitingNCT07610525Phase 2
• Creating Opportunities For Personal Empowerment (COPE) In Women With Breast Cancer During First-Line Therapy: A Pilot Randomized Controlled TrialNot yet recruitingNCT07610499Not applicable
• Phase 1/2 FLAG-IDA, VEN and Asciminib in CML and Ph+ AMLNot yet recruitingNCT07604233Phase 1/2
• Efforts to Increase Representation in Prostate Cancer Clinical Trials at Lyndon B. Johnson HospitalRecruitingNCT07591701Not applicable
• OCRA Distress & Unmet NeedsNot yet recruitingNCT07591623Not applicable
• Barriers And Facilitators To Clinical Trial Enrollment: A Qualitative Study Of Pancreatic Cancer PatientsNot yet recruitingNCT07591480
• Ph1/2 Trial Of Navlimetostat With Pumitamig In MTAP-Deficient Advanced Non-Small Cell Lung CancerRecruitingNCT07579221Phase 1/2
• A Phase1 Clinical Trial Evaluating Locoregional Delivery Of Engineered NK Cells Containing IL13Ra And EGFvIII Chimeric Antigen Receptor (CAR), IL-21 Secretion And Deleted TGF-BetaR2 And NR3C1 In Recurrent GlioblastomaRecruitingNCT07579208Phase 1
• Baseline Anxiety Trajectories in Pediatric Radiation Therapy Observational CohortRecruitingNCT07575815
• Phase 2 Study Of Mosunetuzumab In Patients With Chronic Lymphocytic Leukemia With Positive MRDRecruitingNCT07566364Phase 2
• ACT-GEN (Adherence And Care Tracking In GENetic Cancer Syndromes)Not yet recruitingNCT07565467Not applicable
• Phase 1 Study Of LNK001 In Advanced Or Metastatic Clear Cell Renal Cell CarcinomaRecruitingNCT07564232Phase 1
• Phase 1b Study Of TRICK-NK In Combination With T-Dxd In Treatment-Refractory Breast CancersNot yet recruitingNCT07553390Phase 1
• Phase II Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With CHLRecruitingNCT07551583Phase 2
• Phase I Study Of PLM-102 In Patients With Relapsed And Refractory Acute Myeloid LeukemiaNot yet recruitingNCT07549464Phase 1
• Phase 2 Study Of Imetelstat for Patient With Myelodysplastic/Myeloproliferative NeoplasmsNot yet recruitingNCT07549451Phase 2
• The Impact Of A Patient Support Community On Patients With Neuroendocrine Cervical Cancer: NECC Peer SupportRecruitingNCT07532954
• A Phase 2 Study Of Zanzalintinib For Patients With Recurrent Or Metastatic Olfactory NeuroblastomaNot yet recruitingNCT07527169Phase 2
• Venetoclax, Dexamethasone, Bortezomib, and Daratumumab For The Treatment Of Adolescent And Young Adults With Relapsed Or Refractory T-Cell Acute Lymphoblastic Leukemia And T-cell Acute Lymphoblastic LymphomaRecruitingNCT07513129Phase 1
• Evaluating Intermittent Fasting In Individuals At High Risk ForPancreatic Cancer Undergoing ScreeningRecruitingNCT07513116Not applicable
• PROSECCO: A Phase 2, Single Arm, Neoadjuvant Study Evaluating Combination Cemiplimab, Fianlimab, And Ipilimumab In Patients With Surgically Resectable MelanomaNot yet recruitingNCT07511036Phase 2
• Phase 2 Trial Of Sacituzumab Tirumotecan For Treatment Of Refractory Metastatic Or Unresectable Squamous Cell Carcinoma Of The Anus/RectumNot yet recruitingNCT07511023Phase 2
• Phase 1/2 Window Of Opportunity Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cells Delivered Intraperitoneally For The Management Of Gastric Cancer Metastatic To The PeritoneumRecruitingNCT07509008Phase 1/2
• A Phase 2 Trial Of The Bruton Tyrosine Kinase Degrader BGB-16673 In Combination With BCL-2 Inhibitor Sonrotoclax For Patients With Treatment-Naive Chronic Lymphocytic Leukemia (CLL)RecruitingNCT07508995Phase 2
• Phase1b/2 Trial Of AZA + APG1252 In Patients With High-Risk AMLRecruitingNCT07508982Phase 1/2
• Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal CancerRecruitingNCT07500298Phase 1
• Radiofrequency Ablation For Recurrent Parathyroid CarcinomaRecruitingNCT07475780Not applicable
• Zanzalintinib Plus Cemiplimab for the Treatment of BRAF Wild-Type Anaplastic Thyroid CancerNot yet recruitingNCT07470489Phase 2
• A Study to Evaluate the Safety and Efficacy of Intracranial Venous Blood Sampling for Liquid Biopsy in the Diagnosis of Brain CancersRecruitingNCT07467109
• PREDICTT Clinical Trial: Prospective Evaluation Of Pressure-Enabled Delivery And Alterations In CT-Based Tumor-To-Normal Liver Ratio And Tumor Dose Using The Trinav Infusion SystemRecruitingNCT07444645Not applicable
• Phase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid MalignanciesRecruitingNCT07444632Phase 1
• A Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab (TraPIN) in Pediatric and Young Adult Patients With Recurrent Soft Tissue SarcomasRecruitingNCT07444619Phase 1
• Dose Ranging, Toxicity Seeking, Phase 1 Trial of Oncolytic Adenoviral Therapy for Melanoma Intracranial and Extracranial MetastasesNot yet recruitingNCT07444606Phase 1
• Phase II Trial of Sacituzumab Tirumotecan in Patients With SMARCB1-Deficient Renal Medullary CarcinomaRecruitingNCT07438626Phase 2
• Optimizing Contrast Dose and Scanning Parameters for Detection of Leptomeningeal DiseaseRecruitingNCT07415018Not applicable
• Lorlatinib Plus Local Consolidation Therapy In ALK Positive Advanced Non-Small Cell Lung CancerRecruitingNCT07415005Phase 2
• Phase 1 Study Of Intrathecal Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cells For Patients With Leptomeningeal MelanomaNot yet recruitingNCT07414979Phase 1
• Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial ("Chip-CRC Trial")RecruitingNCT07411599Phase 1/2
• Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR TrialRecruitingNCT07407920Phase 2
• A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK)RecruitingNCT07401875Phase 1
• Phase 1 Study of JV-394 Autologous Anti-CD94 CAR T for r/r CD94+ T/NK Cell NeoplasmsRecruitingNCT07382817Phase 1
• Decoupling Immunotherapy Toxicity and Cancer ResponseRecruitingNCT07382752
• A Phase 2 Study of Radiotherapy-induced Immune Priming to Enhance Elranatamab (Elra) in Relapsed Refractory Multiple Myeloma (RRMM) With Extramedullary Disease (EMD) and Paramedullary Disease (PMD) "PRIME-EMD-PMD"RecruitingNCT07382739Phase 2
• Phase 1 Study Of Izalontamab Brengitecan + Adagrasib In NSCLC - The IZA-A TrialRecruitingNCT07382726Phase 1
• Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System for the Primary Prevention of Endometrial CancerRecruitingNCT07382583
• Adaptation and Pilot Testing of a Lung Cancer Screening Decision Aid for Patients From a Safety-Net Healthcare SystemRecruitingNCT07382557Not applicable
• Phase 1b Trial of BMS-986504 in Combination With Olaparib in Patients With MTAP LossRecruitingNCT07382544Phase 1
• Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate CancerRecruitingNCT07377006Not applicable
• A Randomized Trial Comparing Routine Use of the ActiValve to Standard Voice ProsthesesNot yet recruitingNCT07369050Not applicable
• CARE-BI:a Pilot Study to Improve Patient Comfort and Reduce Psychological Distress During IA RemovalRecruitingNCT07335302
• A Pilot Study to Correlate 4-18F- Fluoro-1-naphthol 18F-4FN PET/CT Imaging With Graft Versus Host Disease ManifestationsRecruitingNCT07325253Phase 2
• ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal CancerRecruitingNCT07318389Early Phase 1
• IGNITE-TX Phase III: (Identifying Individuals for Genetic Testing & Treatment) InterventionNot yet recruitingNCT07318363Phase 3
• Phase Ib Study of Avutometinib, Defactinib, and Everolimus in RAS Pathway Mutant Endometrial CancerRecruitingNCT07318324Phase 1
• Phase 2 Trial of Lisocabtagene Maraleucel for Minimal Residual Disease in Patients With Large B-cell LymphomaRecruitingNCT07316010Phase 2

← M.D. Anderson Cancer Center overview and focus areas